Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBHI.L Regulatory News (BHI)

  • There is currently no data for BHI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

29 Jun 2022 11:49

RNS Number : 6446Q
BMO UK High Income Trust PLC
29 June 2022
 

BMO UK High Income: New Research

29/06/2022

BHI is a high conviction strategy that provides an attractive yield and exposure to high-quality, fast-growing companies…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPUBWQUPPGUB
Date   Source Headline
29th Jun 20223:55 pmRNSChange of Name
29th Jun 202212:56 pmRNSNet Asset Value(s)
29th Jun 202211:49 amRNSKepler Trust Intelligence: New Research
28th Jun 20221:04 pmRNSNet Asset Value(s)
27th Jun 20225:02 pmRNSDividend and Capital Repayment
27th Jun 20221:18 pmRNSNet Asset Value(s)
24th Jun 20221:27 pmRNSNet Asset Value(s)
23rd Jun 20224:08 pmRNSPortfolio Update
23rd Jun 202212:51 pmRNSNet Asset Value(s)
22nd Jun 20221:07 pmRNSNet Asset Value(s)
21st Jun 202212:55 pmRNSNet Asset Value(s)
20th Jun 20224:06 pmRNSNet Asset Value(s)
17th Jun 20222:37 pmRNSNet Asset Value(s)
16th Jun 20221:11 pmRNSNet Asset Value(s)
15th Jun 20221:05 pmRNSNet Asset Value(s)
14th Jun 20221:03 pmRNSNet Asset Value(s)
13th Jun 202212:54 pmRNSNet Asset Value(s)
10th Jun 20221:48 pmRNSNet Asset Value(s)
9th Jun 202212:55 pmRNSNet Asset Value(s)
9th Jun 20229:56 amRNSDoc re Annual Report & AGM
8th Jun 202212:56 pmRNSNet Asset Value(s)
7th Jun 20221:01 pmRNSNet Asset Value(s)
6th Jun 20222:09 pmRNSNet Asset Value(s)
1st Jun 20221:15 pmRNSNet Asset Value(s)
31st May 202212:56 pmRNSNet Asset Value(s)
31st May 20227:00 amRNSAnnual Financial Report
30th May 20221:43 pmRNSNet Asset Value(s)
27th May 202212:59 pmRNSNet Asset Value(s)
26th May 20222:27 pmRNSPortfolio Update
26th May 202212:47 pmRNSNet Asset Value(s)
25th May 202212:52 pmRNSNet Asset Value(s)
24th May 20221:06 pmRNSNet Asset Value(s)
23rd May 20221:21 pmRNSNet Asset Value(s)
20th May 202212:56 pmRNSNet Asset Value(s)
19th May 20221:00 pmRNSNet Asset Value(s)
18th May 202212:51 pmRNSNet Asset Value(s)
17th May 20221:06 pmRNSNet Asset Value(s)
16th May 20221:07 pmRNSNet Asset Value(s)
13th May 20221:12 pmRNSNet Asset Value(s)
12th May 202212:51 pmRNSNet Asset Value(s)
11th May 202212:56 pmRNSNet Asset Value(s)
10th May 20221:03 pmRNSNet Asset Value(s)
9th May 20221:40 pmRNSNet Asset Value(s)
6th May 202212:41 pmRNSNet Asset Value(s)
5th May 202212:53 pmRNSNet Asset Value(s)
4th May 20221:00 pmRNSNet Asset Value(s)
3rd May 20221:43 pmRNSNet Asset Value(s)
29th Apr 20221:02 pmRNSNet Asset Value(s)
28th Apr 202212:51 pmRNSNet Asset Value(s)
27th Apr 202212:56 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.